In addition, there is a high frequency of β-catenin activation in GSD1a patients who develop HCA, leading to an elevated risk of malignant transformation to hepatocellular carcinoma (HCC) within this population [106]. Here, G6PC1 is linked to hepatocellular carcinoma.